Suppr超能文献

更困难的是:在 COVID-19 肺炎的背景下治疗严重的快速进行性肾小球肾炎。

More difficult still: Treating severe rapidly progressive glomerulonephritis in the context of COVID-19 pneumonia.

机构信息

Servicio de Nefrología, Hospital Universitario Infanta Leonor, Madrid, Spain.

Servicio de Nefrología, Hospital Universitario Infanta Leonor, Madrid, Spain.

出版信息

Nefrologia (Engl Ed). 2022 Jan-Feb;42(1):94-98. doi: 10.1016/j.nefroe.2020.12.007. Epub 2022 Feb 17.

Abstract

We present the case of a male patient with severe SARS-CoV-2 pneumonia, with simultaneous onset of p-ANCA positive rapidly progressive glomerulonephritis. We discuss the different therapeutic possibilities, emphasising the appropriateness of their administration according to the time in the course of the infection.

摘要

我们报告了一例男性 SARS-CoV-2 肺炎重症患者,同时发生 p-ANCA 阳性急进性肾小球肾炎。我们讨论了不同的治疗可能性,强调了根据感染过程中的时间来适当使用这些治疗方法的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a84/8851205/0054877e43ea/gr1_lrg.jpg

相似文献

1
More difficult still: Treating severe rapidly progressive glomerulonephritis in the context of COVID-19 pneumonia.
Nefrologia (Engl Ed). 2022 Jan-Feb;42(1):94-98. doi: 10.1016/j.nefroe.2020.12.007. Epub 2022 Feb 17.
2
More difficult still: Treating severe rapidly progressive glomerulonephritis in the context of COVID-19 pneumonia.
Nefrologia (Engl Ed). 2021 Jan 28;42(1):94-8. doi: 10.1016/j.nefro.2020.12.006.
3
ANCA-associated glomerulonephritis and lupus nephritis following COVID-19 vaccination: a case report and literature review.
Front Immunol. 2024 Jan 8;14:1298622. doi: 10.3389/fimmu.2023.1298622. eCollection 2023.
4
MPO-ANCA-positive Microscopic Polyangiitis Following COVID-19 Infection.
Intern Med. 2022 Feb 15;61(4):567-570. doi: 10.2169/internalmedicine.8615-21. Epub 2021 Nov 27.
6
Rapidly progressive glomerulonephritis due to systemic lupus erythematosus and ANCA-associated vasculitis overlap.
Lupus. 2020 Jul;29(8):983-986. doi: 10.1177/0961203320920368. Epub 2020 Apr 21.
7
ANCA-negative pauci-immune crescentic glomerulonephritis.
Nat Rev Nephrol. 2009 Jun;5(6):313-8. doi: 10.1038/nrneph.2009.67. Epub 2009 Apr 28.
8
A Rare Case of Double Antibody-Positive Rapidly Progressive Glomerulonephritis: A Therapeutic Challenge.
J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211013193. doi: 10.1177/23247096211013193.
9
Interstitial nephritis without glomerulonephritis in ANCA-associated vasculitis: a case series and literature review.
Clin Rheumatol. 2022 Nov;41(11):3551-3563. doi: 10.1007/s10067-022-06264-2. Epub 2022 Jun 27.

引用本文的文献

1
Ascertaining the mechanistic etiology of COVID-associated glomerulonephritis: a systematic review.
Front Med (Lausanne). 2025 Jun 9;12:1568943. doi: 10.3389/fmed.2025.1568943. eCollection 2025.
2
A Rare Case of ANCA-negative Rapidly Progressive Glomerulonephritis: A Case Report.
J Community Hosp Intern Med Perspect. 2024 Jul 2;14(4):75-78. doi: 10.55729/2000-9666.1371. eCollection 2024.
3
Mechanisms of thrombosis in ANCA-associated vasculitis.
Clin Rheumatol. 2021 Dec;40(12):4807-4815. doi: 10.1007/s10067-021-05790-9. Epub 2021 Jun 9.

本文引用的文献

1
Mild COVID-19 in ANCA-associated vasculitis treated with rituximab.
Ann Rheum Dis. 2021 Jun;80(6):e99. doi: 10.1136/annrheumdis-2020-218246. Epub 2020 Aug 7.
2
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases.
Clin Exp Immunol. 2020 Nov;202(2):149-161. doi: 10.1111/cei.13495. Epub 2020 Aug 1.
3
Convalescent plasma for persisting COVID-19 following therapeutic lymphocyte depletion: a report of rapid recovery.
Br J Haematol. 2020 Aug;190(3):e154-e156. doi: 10.1111/bjh.16981. Epub 2020 Jul 16.
4
Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature.
Br J Haematol. 2020 Jul;190(2):185-188. doi: 10.1111/bjh.16896. Epub 2020 Jun 22.
5
Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab.
Ann Rheum Dis. 2021 Mar;80(3):e37. doi: 10.1136/annrheumdis-2020-217864. Epub 2020 Jun 5.
6
Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia.
Ann Rheum Dis. 2021 Jan;80(1):e10. doi: 10.1136/annrheumdis-2020-217549. Epub 2020 Apr 20.
7
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.
Ann Rheum Dis. 2020 May;79(5):667-668. doi: 10.1136/annrheumdis-2020-217424. Epub 2020 Apr 2.
9
Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab.
Semin Arthritis Rheum. 2015 Aug;45(1):48-54. doi: 10.1016/j.semarthrit.2015.02.002. Epub 2015 Feb 20.
10
Successful treatment of refractory aortitis in antineutrophil cytoplasmic antibody-associated vasculitis using tocilizumab.
Clin Rheumatol. 2014 Feb;33(2):287-9. doi: 10.1007/s10067-013-2457-2. Epub 2013 Dec 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验